|
Note 8 – Compensation and Benefit Plans: |
|
The aggregate remuneration paid to all officers and directors during the year ended June 30, 2024 was $1,468,900 and $135,000, respectively. |
|
Employees of the Company may participate in a voluntary defined contribution plan (the "401K Plan") qualified under Section 401(k) of the Internal Revenue Code of 1986. Under the 401K Plan, employees who have met certain age and service requirements may contribute up to a certain percentage of their compensation. The Company has made contributions of $17,000 (2024), $21,000 (2023) and $25,000 (2022). |
|
In November 1995, the Company’s stockholders approved the 1995 Equity Participation Plan (the “1995 Plan”). Under the 1995 Plan, the maximum number of shares of common stock that can be issued increases by an amount equal to 1% of the total number of issued and outstanding shares of common stock as of June 30 of each fiscal year. Shares available for grant for the years ending June 30, 2024 and 2023 are 3,032,642 and 2,939,548, respectively. There have been no option grants awarded since fiscal 2013, and at June 30, 2024 there were no options outstanding and no stock-based compensation expense was recognized in the year ended June 30, 2024. |
|
Note 9 – Capital Structure |
|
At June 30, 2024, the Company has 20,000,000 authorized shares of common stock and is authorized to issue 2,500,000 shares of preferred stock in one or more series, fix the voting powers, designations, preferences and the relative participation, optional or other rights, if any, of any wholly unissued series of preferred stock. The Company declared one distribution to holders of Common Stock in fiscal 2024, $.40 per share paid on June 26, 2024 in cash. Under current tax regulation, the dividends paid are considered qualified dividends for tax purposes. |
On December 5, 2023, the Company purchased a total of 394,069 shares of common stock at a price of $16.50 per share pursuant to a tender offer made to all shareholders. The aggregate cost resulted in a reduction to stockholders’ equity of $6,566,774. |
On December 15, 2022, the Company purchased a total of 580,683 shares of common stock at a price of $16.00 per share pursuant to a tender offer made to all shareholders. The aggregate cost resulted in a reduction to stockholders’ equity of $9,362,400. |
|
Note 10 – Commitments and Contingencies: |
|
The Company has commitments to extend credit provided there is no violation of any condition in the terms of the approval or agreement. At June 30, 2024 and 2023, the Company had unfunded lease commitments of $2.9 million and $4.7 million, respectively. |